| 1 |
SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer statistics, 2022 [J]. CA Cancer J Clin, 2022, 72(1): 7-33.
|
| 2 |
SILVA L G O, LEMOS F F B, LUZ M S, et al. New avenues for the treatment of immunotherapy-resistant pancreatic cancer [J]. World J Gastrointest Oncol, 2024, 16(4): 1134-1153.
|
| 3 |
TURANLI B, YILDIRIM E, GULFIDAN G, et al. Current state of “omics” biomarkers in pancreatic cancer [J]. J Pers Med, 2021, 11(2): 127.
|
| 4 |
NURMI H, BACKMAN A P E, HALIN J, et al. Glycolipid transfer protein knockout disrupts vesicle trafficking to the plasma membrane [J]. J Biol Chem, 2023, 299(4): 104607.
|
| 5 |
HUANG M H, LI H, XUE R, et al. Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication [J]. Acta Pharm Sin B, 2019, 9(4): 769-781.
|
| 6 |
MISHRA S K, STEPHENSON D J, CHALFANT C E, et al. Upregulation of human glycolipid transfer protein (GLTP) induces necroptosis in colon carcinoma cells[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2019, 1864(2): 158-167.
|
| 7 |
SHI Y L, LIU M B, WU H T, et al. GLTP is a potential prognostic biomarker and correlates with immunotherapy efficacy in cervical cancer [J]. Dis Markers, 2022, 2022: 9109365.
|
| 8 |
ZHANG Y Q, NG P K, KUCHERLAPATI M, et al. A pan-cancer proteogenomic atlas of PI3K/AKT/mTOR pathway alterations[J]. Cancer Cell, 2017, 31(6): 820-832.e3.
|
| 9 |
SHARMA N, NANTA R, SHARMA J, et al. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth [J]. Oncotarget, 2015, 6(31): 32039-32060.
|
| 10 |
XU J, GONG L J, QIAN Z Y, et al. ERBB4 promotes the proliferation of gastric cancer cells via the PI3K/Akt signaling pathway[J]. Oncol Rep, 2018, 39(6): 2892-2898.
|
| 11 |
THIBAULT B, RAMOS-DELGADO F, PONS-TOSTIVINT E, et al. Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component[J]. EMBO Mol Med, 2021, 13(7): e13502.
|
| 12 |
SHAW A E, REID S M, EBERT K, et al. Implementation of a one-step real-time RT-PCR protocol for diagnosis of foot-and-mouth disease[J]. J Virol Methods, 2007, 143(1): 81-85.
|
| 13 |
KENOTH R, BROWN R E, KAMLEKAR R K. In vitro measurement of sphingolipid intermembrane transport illustrated by GLTP superfamily members[J]. Methods Mol Biol, 2019, 1949: 237-256.
|
| 14 |
MALININA L, PATEL D J, BROWN R E. How α-helical motifs form functionally diverse lipid-binding compartments[J]. Annu Rev Biochem, 2017, 86: 609-636.
|
| 15 |
MALININA L, SIMANSHU D K, ZHAI X H, et al. Sphingolipid transfer proteins defined by the GLTP-fold[J]. Q Rev Biophys, 2015, 48(3): 281-322.
|
| 16 |
MISHRA S K, GAO Y G, ZOU X Q, et al. Emerging roles for human glycolipid transfer protein superfamily members in the regulation of autophagy, inflammation, and cell death[J]. Prog Lipid Res, 2020, 78: 101031.
|
| 17 |
ZHANG Y Q, JI S Y, ZHANG X Y, et al. Human CPTP promotes growth and metastasis via sphingolipid metabolite ceramide and PI4KA/AKT signaling in pancreatic cancer cells [J]. Int J Biol Sci, 2022, 18(13): 4963-4983.
|
| 18 |
ZHANG Y Q, ZHANG X Y, LU M Y, et al. Ceramide-1-phosphate and its transfer proteins in eukaryotes [J]. Chem Phys Lipids, 2021, 240: 105135.
|
| 19 |
WADHWA B, MAKHDOOMI U, VISHWAKARMA R, et al. Protein kinase B: emerging mechanisms of isoform-specific regulation of cellular signaling in cancer [J]. Anticancer Drugs, 2017, 28(6): 569-580.
|
| 20 |
SHAN K S, BONANO-RIOS A, THEIK N W Y, et al. Molecular targeting of the phosphoinositide-3-protein kinase (PI3K) pathway across various cancers [J]. Int J Mol Sci, 2024, 25(4): 1973.
|
| 21 |
GLAVIANO A, FOO A S C, LAM H Y, et al. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer [J]. Mol Cancer, 2023, 22(1):138.
|
| 22 |
DRESCHERS S, PLATEN C, OPPERMANN L, et al. EGF-receptor against amphiregulin (AREG) influences costimulatory molecules on monocytes and T cells and modulates T-Cell responses[J]. J Immunol Res, 2023, 2023: 8883045.
|
| 23 |
WANG L, WANG L L, ZHANG H, et al. AREG mediates the epithelial-mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF-κB signalling pathway[J]. Oncol Rep, 2020, 43(5):1558-1568.
|
| 24 |
CASANOVAS O, HICKLIN D J, BERGERS G, et al. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors [J]. Cancer Cell, 2005, 8(4): 299-309.
|